In 1998, efavirenz was approved for treatment of HIV infection, but patients soon began to report bizarre dreams, hallucinations and feelings of unreality. In South Africa, it’s become a recreational drug.
In 1998, efavirenz was approved for treatment of HIV infection, but patients soon began to report bizarre dreams, hallucinations and feelings of unreality. In South Africa, it’s become a recreational drug.
